Basic Information
ID: ALA3540353
Type: ADME
Description: Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 2 hrs by HPLC analysis
Organism: Homo sapiens
Tissue: Plasma
Activity Charts
Bioactivity
Activity Types for Assay ALA3540353
Compound recovery
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 370.38 | 3.52 | 3.52 |
| 312.30 | 3.46 | 3.46 |
| 488.43 | 1.03 | 1.03 |
| 466.45 | 2.53 | 2.53 |
| 392.37 | 2.94 | 2.94 |
| 546.51 | 1.43 | 1.43 |
| 400.37 | 2.91 | 2.91 |
| 386.38 | 2.70 | 2.70 |
| 422.35 | 2.33 | 2.33 |
| 450.45 | 3.35 | 3.35 |
| 370.34 | 3.22 | 3.22 |